By bypassing the process of absorbing vitamins that are consumed orally into the body to eventually be able to experience the benefits through the fraction of what the body was able to absorb, vitamin injections provide much faster and more effective benefits of taking vitamins
AOD-9604 FDA Approval History At a glance FDA approval status / Never approved for any indication in the United States NDA filing history / No New Drug Application has ever been submitted to FDA Chemical identity / Synthetic peptide corresponding to amino acids 176-191 of human growth hormone, with a tyrosine residue added at the C-terminus Developer / Metabolic Pharmaceuticals Ltd (Melbourne, Australia), now defunct Clinical trial outcome / Phase IIb trial (2007) failed to meet primary efficacy endpoint for obesity FDA compounding status / Placed on Category 2 list
With regular B12 injections and a combination of other weight loss regimens, people have reported to lose weight much faster than they wouldve otherwise done without B12
The damage is induced by direct and indirect effects of radiation
Scientific Classification A small-molecule quinolinium derivative and selective nicotinamide N-methyltransferase (NNMT) inhibitor
Bottom line: AOD-9604 is a promising fat-loss peptide that fills a niche between lifestyle interventions and pharmaceutical therapeutics but it should be approached with caution given its regulatory status and limited clinical data.
